Keywords
arterial hypertension, left ventricular hypertrophy, lisinopril, hydrochlorothiazide.
How to Cite
Illiash, M., Bazyka, O., & Starshova, O. (2013). Some aspects of the combined treatment of arterial hypertension. The Practitioner, (2), 40-42. Retrieved from https://plr.com.ua/index.php/journal/article/view/460
Abstract
The paper presents the results of a 12-week antihypertensive therapy by fixed combination of lisinopril and hydrochlorothiazide of 26 patients with mild and moderate arterial hypertension (AH). In 100% of patients, the target blood pressure (BP) was achieved. The therapy was accompanied by normalization of structure and functional state of the heart and hemodynamics, it was effective and safe, had good clinical tolerance, which allows to recommend it for appointment to patients with mild and moderate hypertension.
References
1. European Society of Hypertension - European Society of Cardiology Committee: 2007 ESH/ESC guidelines for management of arterial hypertension//
Eur. Heart J., 2007, V.28(12):1462-1536.
2. Рабочая группа по артериальной гипертензии Украинской ассоциации кардиологов. Оценка риска у больного с артериальной гипер-
тензией//Укр. кардиол. журнал. - 2006. - № 3 (доп.1). - С. 4-6.
3. Воронков Л.Г., Ильяш М.Г., Целуйко В.И., Дядык А.И. Клиническая эффективность и безопасность комбинации лизиноприла и гидро-
хлортиазида // Ліки України. - 2007. - №109. - С. 46-49.
4. Schmieder R.E., Martus P., Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension: A meta-analysis of randomizeddoubleblind
studies// JAMA. -1996. - V.275. - P. 1507-1513.
5. Terpstra W.E, May J.F., Smith A.J. et al. Long-term effects of amlodypine and lisinopril on left ventricular mass and diastolicfunction in elderly,
non-treated hypertensive patients: ELVERAstudy//J.Hypertension. - 2001. - V.I9. - P. 303 -309.
6. Basso N., Paglia N., Stella I. et al. Protective effect of the inhibition of the reninangiotensin system on aging//Reg.Pep. - 2005. - Vol.30, №3. - P. 247-252.
7. Fogari R., Mugellini A., Zoppi A., Destro M. et al. Effect of telmisartan / hydrochlorthiazide vs lisinopril/hydrochlorthiazide combination on
ambulatory blood pressure and cognitive function in elderly hypertensive patients // J. Hum. Hypertens. - 2006. -Vol.20, №3. - P. 177-185.
8. Heesen W.F., Beltman F.W., Smit A.J. Reversal of pathophysiologic changes with long-therm lisinopril treatment in isolated systolic hypertension
// J. Cardiovasc. Pharmacol. - 2001. - Vol. 37, №5. - P. 512-521.
9. American Society of Echocardiography Commitete on Standards. Recomendations for quantification of the left ventricle by two dimensional
echocardiography // J. Amer. Soc. Echo. - 1989. - V.2. - P. 358-367.
10. Petretta M., Bonaduce D., Marciano F. et al. Effect of Year of Lisinopril Treatment on Cardiac Autonomic Control in Hypertensive Patients With Left
Ventricular hypertrophy // Hypertension. - 1996. - Vol.27. - P. 330-338.
11. Wong G.C., Marcotte F., Rudski L.G. Impact of chronic lisinopril therapy on left atrial volume versus dimension in chronic organic mitral
regurgitation // Can. J. Cardiol. - 2006 - Vol.22, №2. - P. 125-129. SOME
Eur. Heart J., 2007, V.28(12):1462-1536.
2. Рабочая группа по артериальной гипертензии Украинской ассоциации кардиологов. Оценка риска у больного с артериальной гипер-
тензией//Укр. кардиол. журнал. - 2006. - № 3 (доп.1). - С. 4-6.
3. Воронков Л.Г., Ильяш М.Г., Целуйко В.И., Дядык А.И. Клиническая эффективность и безопасность комбинации лизиноприла и гидро-
хлортиазида // Ліки України. - 2007. - №109. - С. 46-49.
4. Schmieder R.E., Martus P., Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension: A meta-analysis of randomizeddoubleblind
studies// JAMA. -1996. - V.275. - P. 1507-1513.
5. Terpstra W.E, May J.F., Smith A.J. et al. Long-term effects of amlodypine and lisinopril on left ventricular mass and diastolicfunction in elderly,
non-treated hypertensive patients: ELVERAstudy//J.Hypertension. - 2001. - V.I9. - P. 303 -309.
6. Basso N., Paglia N., Stella I. et al. Protective effect of the inhibition of the reninangiotensin system on aging//Reg.Pep. - 2005. - Vol.30, №3. - P. 247-252.
7. Fogari R., Mugellini A., Zoppi A., Destro M. et al. Effect of telmisartan / hydrochlorthiazide vs lisinopril/hydrochlorthiazide combination on
ambulatory blood pressure and cognitive function in elderly hypertensive patients // J. Hum. Hypertens. - 2006. -Vol.20, №3. - P. 177-185.
8. Heesen W.F., Beltman F.W., Smit A.J. Reversal of pathophysiologic changes with long-therm lisinopril treatment in isolated systolic hypertension
// J. Cardiovasc. Pharmacol. - 2001. - Vol. 37, №5. - P. 512-521.
9. American Society of Echocardiography Commitete on Standards. Recomendations for quantification of the left ventricle by two dimensional
echocardiography // J. Amer. Soc. Echo. - 1989. - V.2. - P. 358-367.
10. Petretta M., Bonaduce D., Marciano F. et al. Effect of Year of Lisinopril Treatment on Cardiac Autonomic Control in Hypertensive Patients With Left
Ventricular hypertrophy // Hypertension. - 1996. - Vol.27. - P. 330-338.
11. Wong G.C., Marcotte F., Rudski L.G. Impact of chronic lisinopril therapy on left atrial volume versus dimension in chronic organic mitral
regurgitation // Can. J. Cardiol. - 2006 - Vol.22, №2. - P. 125-129. SOME
Downloads
Download data is not yet available.